Please ensure Javascript is enabled for purposes of website accessibility
Home / Information / Highlights

A Beginner’s Guide to Choosing the Right Recombinant Protein Expression System
2025-12-30 71

When starting recombinant protein expression, many beginners quickly encounter the same fundamental question:
“Which expression system should I choose for my protein?”

E. coli, yeast, insect cells, mammalian cells—there seems to be no shortage of options.
What truly causes confusion, however, is not what systems exist, but rather why the same gene can yield dramatically different results when expressed in different systems.

The answer is actually quite straightforward: different expression systems differ greatly in their ability to properly “handle” a protein.

 

I. A Core Concept to Understand First

The essential differences between expression systems go far beyond simply “which host cell is used” or “whether the protein can be expressed at all.”
At their core, these systems differ in whether they can produce the protein correctly.

Here, “correctly” refers to several critical aspects:

  • Proper protein folding
  • Appropriate post-translational modifications (PTMs)
  • Retention of native biological activity

Not every expression system is capable of meeting all these requirements.

 

II. Overview of Major Expression Systems

1. Escherichia coli Expression System

For many researchers, E. coli is the first expression system they encounter. It is a prokaryotic system that is highly efficient, but relatively poor at caring for complex proteins. Its advantages are obvious: rapid growth, simple operation, low cost, and often very high expression yields. As a result, E. coli is well suited for proteins of prokaryotic origin or proteins with relatively simple structures that do not rely on post-translational modifications.

However, these strengths also define its limitations. E. coli lacks the folding machinery and post-translational modification pathways found in eukaryotic cells. When used to express eukaryotic proteins—especially at high expression levels—misfolding and inclusion body formation are common. In practice, this often manifests as strong Western blot signals but little to no biological activity, or poor protein solubility. Importantly, this is not necessarily due to experimental error, but rather reflects intrinsic limitations of the system itself.

2. Yeast Expression System

When protein folding becomes more demanding, yeast expression systems are often considered an upgrade. Yeast are lower eukaryotes that possess basic eukaryotic folding mechanisms, including disulfide bond formation and simple glycosylation, while still maintaining relatively fast growth and moderate cost.

For proteins that require basic post-translational modifications but are not highly sensitive to glycosylation patterns, yeast can offer an attractive balance between performance and cost. However, it is important to note that yeast glycosylation differs fundamentally from that of mammalian cells. Yeast predominantly produce high-mannose-type glycans, which may affect protein stability, serum half-life, or even biological function in certain applications.

Thus, the key question when using yeast is often not whether the protein can be expressed, but whether the downstream application can tolerate these glycosylation differences.

3. Insect Cell–Baculovirus Expression System

For projects seeking higher success rates without the full cost and complexity of mammalian cell culture, the insect cell–baculovirus system is often a highly reliable option. This system offers protein folding, solubility, and post-translational modification capabilities that closely approximate those of mammalian cells.

In practice, many proteins that repeatedly fail in E. coli can be successfully expressed in insect cells. This system is particularly well suited for secreted proteins, structurally complex proteins, and extracellular domains of membrane proteins. While insect cell expression involves longer timelines and higher costs than bacterial or yeast systems, its overall robustness makes it a widely used and trusted platform in academic research.

4. Mammalian Cell Expression System

When protein function is highly dependent on native conformation and precise post-translational modifications, the range of viable options becomes limited. Mammalian expression systems are considered the gold standard because they most closely replicate the protein’s natural state in the human body.

Complex N-linked glycosylation, subtle conformational features, and protein–protein interaction interfaces are all best reproduced in mammalian cells. Consequently, mammalian expression is often indispensable for therapeutic antibodies, receptor proteins, critical cytokines, and any protein where biological activity must be preserved with high fidelity.

These advantages, however, come with practical trade-offs: longer culture times, higher operational complexity, and significantly increased cost.

Comparative overview of the characteristics associated with the major gene expression systems(STAR Protoc. 2023 Oct 31;4(4):102572.)

Practical Tips for Beginners

For newcomers to recombinant protein expression, a simple and practical decision-making strategy can be extremely helpful. If the protein originates from a prokaryote and has a simple structure, E. coli is often the most efficient starting point. For proteins derived from eukaryotic organisms—especially secreted or membrane proteins—eukaryotic expression systems should be considered early on.

As protein size increases, the number of disulfide bonds grows, or functional dependence on glycosylation becomes evident, the risks associated with prokaryotic expression increase dramatically.

In practical terms:

· Low-cost, high-yield expression of structurally simple proteins → E. coli

· Proteins requiring basic modifications but insensitive to glycan structure → Yeast

· Structurally complex proteins with higher success-rate requirements → Insect cells

· Proteins where native structure and function are non-negotiable → Mammalian cells

Decision scheme for gene expression system selection

(STAR Protoc. 2023 Oct 31;4(4):102572.)

 

AntibodySystem provides Active Protein and Recombinant Protein products, delivering more tools and solutions for research.

 

Active Protein

Catalog No.

Product name

AHB39502

Recombinant Human CD335/NCR1/NKp46 Protein, C-His (Active)

AHC06701

Recombinant Human CSF2/GM-CSF Protein, C-His (Active)

AHC13501

Recombinant Human IL4 Protein, C-His (Active)

AHC14301

Recombinant Human SERPING1 Protein, C-His (Active)

AHC30501

Recombinant Human CD271/NGFR Protein, C-hFc-His (Active)

AHC35001

Recombinant Human CD16a/FCGR3A (F176) Protein, C-His (Active)

AHC94101

Recombinant Human GZMA/Granzyme A Protein, C-10*His (Active)

AHD69401

Recombinant Human PTX3 Protein, C-His (Active)

AHE01701

Recombinant Human CD50/ICAM3 Protein, C-hFc-His (Active)

AHE79001

Recombinant Human CD239/BCAM Protein, C-His (Active)

AHJ64101

Recombinant Human ESM1 Protein, C-10*His (Active)

AHJ73201

Recombinant Human DKK3 Protein, C-His (Active)

AHK15501

Recombinant Human SEMA4C Protein, C-hFc (Active)

AMB89901

Recombinant Mouse C3/Complement C3 Protein, C-His (Active)

AMB90001

Recombinant Mouse C5/Complement C5 Protein, No tag (Active)

AMC42101

Recombinant Mouse CSF1/M-CSF Protein, C-His (Active)

AMD29101

Recombinant Mouse LBP Protein, C-His (Active)

AME70701

Recombinant Mouse Flt3 ligand/FLT3LG Protein, C-hFc-His (Active)

APC06701

Recombinant Pig CSF2/GM-CSF Protein, C-His (Active)

ARB95301

Recombinant Rat IFNB1/IFN-beta Protein, C-His (Active)

 

Recombinant Protein

Catalog No.

Product name

EVV00348

Recombinant SARS-CoV-2 RBD (XDV.1) Protein, C-Fc

EVV03501

Recombinant RABV G/Glycoprotein, C-His

EVV03502

Recombinant Rabies virus/RABV G/Glycoprotein Protein, C-10*His

EVV12704

Recombinant MPXV H3L Protein, C-His

EVV12703

Recombinant Monkeypox virus (MPXV) H3L Protein, C-Fc

EVV18201

Recombinant Langya virus/LayV F/Fusion Protein, C-His

YHA19001

Recombinant Human UBE2C Protein, N-His

YHA19301

Recombinant Human SCD Protein, N-His

YHA17301

Recombinant Human PIR Protein, N-His

YHA16901

Recombinant Human FCN1 Protein, N-His

YHA11501

Recombinant Human DRP1/DNM1L Protein, N-His

YHA05301

Recombinant Human CD284/TLR4 Protein, N-His

EVV02801

Recombinant HRSV-A2 Pre-F/Fusion glycoprotein F0 Protein, C-His-Strep

EVV03001

Recombinant HBV S/L-HBsAg/L glycoprotein Protein, C-S Tag

EVV15201

Recombinant EBV/HHV4 BLLF1/MA/GP350 Protein, C-His

EVV09701

Recombinant CHIKV Spike glycoprotein E2 Protein, C-Fc

EVV16002

Recombinant ASFV p54/pE183L Protein, C-His

Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only